期刊文献+

高危队列人群血浆氨基末端脑钠肽前体浓度与左室舒张功能相关性的探讨 被引量:6

Relationship between N-terminal pro-brain natriuretic peptide and diastolic heart function on the population in community at high risk of developing cardiovascular diseases
原文传递
导出
摘要 目的:探讨社区心血管疾病高危队列人群血浆氨基末端脑钠肽前体(N-terminal pro-brain natriuretic peptide,NT-proBNP)浓度与左室舒张功能分级的关系。方法:横断面调查北京首钢社区733例具有心血管病高危因素的人群,运用电化学发光免疫技术测定血浆NT-proBNP浓度。行超声心动图测量左室射血分数(LVEF),并依据二尖瓣口血流多普勒、二尖瓣环组织多普勒、肺动脉血流多普勒对LVEF正常者进行左室舒张功能分级(正常、轻度受损、中/重度受损、未定型);分析LVEF正常者血浆NT-proBNP浓度正常与升高者左室舒张功能差异,以及左室舒张功能分级与血浆NT-proBNP浓度的相关性。结果:在LVEF正常的人群中,血浆NT-proBNP浓度正常者与升高者的左室舒张功能分级差异有统计学意义(P=0.012),年龄、性别、心率与血浆NT-proBNP浓度相关,校正上述因素后左室舒张功能分级(rp=0.053,P=0.021)与血浆NT-proBNP浓度独立相关。结论:LVEF正常人群中血浆NT-proBNP浓度升高者其左室舒张功能减低,而且左室舒张功能受损程度与血浆NT-proBNP浓度呈正相关,血浆NT-proBNP浓度升高可作为左室舒张功能受损早期诊断、干预的依据。 Objective:To analyze the relationship between N-terminal pro-brain natriuretic peptide and diastolic heart function on the population in community at high risk of developing cardiovascular diseases.Method:The automated electrochemiluminescence immunoassay was used to measure concentration of serum NT-proBNP,and images was consecutively collected with Echocardiography.Totally 733 people in Peking Shougang community at high risk of developing cardiovascular diseases was cross-sectional studied.Left ventricular ejection fraction(LVEF) were measured,diastolic heart function was classified by Doppler images of mitral inflow maneuver,Doppler images of pulmonary venous flow,and Doppler tissure images of mitral annular motion.The diastolic heart function of those whose LVEF are normal ware were analyzed,they ware were grouped by if the serum NT-proBNP is normal or not.And the relationship between serum NT-proBNP and diastolic heart function was also assessed.Result:The difference of diastolic heart function was significant in each group if serum NT-proBNP was normal or not(P=0.012).Age,sex,heart rate respectively correlated with serum NT-proBNP,and after adjusting those factors the diastolic heart function independently correlated with serum NT-proBNP.Conclusion:The diastolic heart function of population with normal LVEF and higher serum NT-proBNP is impaired.And the diastolic heart function positive correlated with serum NT-proBNP.So serum NT-proBNP can be an objective index which can reflect the diastolic heart function.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2010年第5期364-368,共5页 Journal of Clinical Cardiology
基金 "十一五"国家科技支撑计划:冠心病早期诊断和综合治疗技术体系的研究(No:2006BAI01A02)
关键词 舒张功能 超声心动描记术 氨基末端脑钠肽前体 diastolic function echocardiography N-terminal pro-brain natriuretic peptide
  • 相关文献

参考文献16

  • 1YOSHIMURA M, YASUE H, OKAMURA K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure[J]. Circulation, 1993,87 : 464- 469.
  • 2COWIE M R, STRUTHERS A D, WOOD D A, et al. Value of natrouretic peptides in assessment of patients with possible new heart failure in primary care [J]. Lancet,1997 ,350:1347-1351.
  • 3夏思良,周建松,郭振峰,孙红.老年慢性心力衰竭患者血浆脑钠肽前体与左室功能研究[J].实用老年医学,2009,23(1):42-44. 被引量:11
  • 4LIU L, ZHAO F, YANG Y, et al. The clinical significance of carotid intima-media thickness in cardiovascular diseases:a survey in Beijing[J]. J Hum Hypertens, 2008,22 : 259- 265.
  • 5REDFIELD M M, JACOBSEN S J, BURNETT J C, Jr, et al. Burden of systolic and diastolic ventrieular dysfunction in the community[J]. JAMA, 2003,289 : 194-202.
  • 6DOUST J A, GLASZIOU P P, PIETRZAK E, et al. A systematic review of the diagnostic accuracy of natriuretic peptide for heart failure[J]. Arch Interm Med, 2004,164 : 1978- 1984.
  • 7MUKOYAMA M, NAKAO K, SAITO Y, et al. Increased human brain natriuretic peptide in congestive heart fail ure[J]. N Engl J Med, 1990,32a : 757- 758.
  • 8TSCHOPE C, KASNER M, WESTERMANN D, et al. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements[J].Eur Heart J, 2005,26 : 2277- 2284.
  • 9IWANAGA Y, NISHI I, FURUICHI S, et al. B- type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure[J]. J Am Coll Cardiol, 2006,47 : 742 - 748.
  • 10SUZUKI T, YAMAOKI K, NAKAJIMA O, et al. Screening for cardiac dysfunc-tion in asymptomatic patients by measuring B type natriuretic peptidelevels[J]. Jpn Heart J,2000,41:205-214.

二级参考文献20

  • 1夏瑾玮,邵淮鲁,王蓓云,陆懿,金俊.高血压患者血浆BNP水平与左心功能不全的关系[J].实用老年医学,2005,19(2):82-84. 被引量:9
  • 2Seino Y, Ogawa A, Yanmashita T, et al. Application of NTproBNP and BNP measurements in cardiac care:a more disceming marker for the detection and evaluation of heart failure [ J ]. Eur J Heart Fail, 2004,6 ( 3 ) :295-300.
  • 3Rothenburger M, Wichter T, Schmid C, et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure [ J ]. J Heart Lung Transplant,2004,23 (10) : 1189-1197.
  • 4Groenning BA, Raymod I, Hildebrandt PR, et al. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population [J]. Heart,2004,90(3):297-303.
  • 5Hartmann F, Packer M, Coats A, et al. Prognosis impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure [ J ]. Circulation, 2004,110 ( 13 ) : 1780-1786.
  • 6Troughton RW, Frampton CM, Yandle TG,et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations [ J ]. Lancet, 2000,355 (9210) :1126-1130.
  • 7Yeo KTJ,Wu AHB, Apple FS, et al. Muhicenter evaluation of the Roche NT-proBNP assay and comparison to the biosite triage BNP assay [ J ]. Clin Chem Acta, 2003,338 (112) : 107-115.
  • 8Cauliez B,Guignery S, Marinier S, et al. Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system[ J ]. Ann Clin Biochem, 2008,45 ( Pt 3) :318-319.
  • 9Emdin M, Passino C, Prontera C, et al. Comparison of brain natriuretic peptide(BNP) and amio-terminal proBNP for early diagnosis of heart failure [ J]. Clinical Chemistry,2007,53 ( 7 ) : 1289-1297.
  • 10Grewal J, McKelvie RS, Persson H, et al. Usefulness of Nterminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction [ J]. Am J Cardiol,2008,102(6) :733-737.

共引文献28

同被引文献79

  • 1Rosca M, Lancellotti P, Popescu BA, et al. Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart,2011,97 : 1982-1989.
  • 2Blume GG, Mcleod CJ, Barnes ME, et al. Left atrial function: physiology, assessment, and clinical implications. Eur J Echoeardiogr,2011,12:421-430.
  • 3Thomas L. Assessment of atrial function. Heart Lung Circ, 2007,16 : 234-242.
  • 4To AC, Flamm SD, Marwick TH, et al. Clinical utility of multimodality LA imaging assessment of size, function, and structure. JACC Cardiovasc Imaging, 2011,4 : 788-798.
  • 5Cuspidi C, Meani S, Fusi V, et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study. J Hypertens, 2005, 23: 875-882.
  • 6Liu L,Zhao F, Yang Y, et al. The clinical significance of carotid intima-media thickness in cardiovascular diseases: a survey in Beijing. J Hum Hypertens, 2008,22 : 259 -265.
  • 7Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography' s Guidelines and Standards Committee and the Chamber Quantification writing group, developed in conjunction with European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echoeardiogr, 2005,18 : 1440-1463.
  • 8Mondillo S, Cameli M, Caputo ML, et al. Early detection of left atrial strain abnormalities by speckle-tracking in hypertensive and diabetic patients with normal left atrial size. J Am Soc Echocardiogr, 2011,24:651-662.
  • 9Saraiva RM,Demirkol S,Buakhamsri A,et al. Left atrial strain measured by two-dimensional speckle tracking represents a new tool to evaluate left atrial function. J Am Soc Echocardiogr, 2010,23:172- 180.
  • 10Vianna-Pinton R, Moreno CA, Baxter CM, et al. Two- dimensional speckle tracking echocardiography of the left atrium: feasibility and regional contraction and relaxation differences in normal subjects. J Am Soc Echocardiogr, 2009,22 : 299-305.

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部